Ionis Pharmaceuticals, Inc.
IONS · NASDAQ
10/28/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $12 | $6 | $5 | $6 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $1 | $1 | $2 | $1 |
| Enterprise Value | $13 | $7 | $6 | $7 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -65.3% | 243.5% | -41.9% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 98.5% | 99.1% | 98.9% | 98.3% |
| EBITDA | -$0 | $0 | -$0 | -$0 |
| % Margin | -60.2% | 33.2% | -91.2% | -35.5% |
| Net Income | -$0 | $0 | -$0 | -$0 |
| % Margin | -82.1% | 27.3% | -111.6% | -46.1% |
| EPS Diluted | -0.8 | 0.68 | -0.93 | -0.66 |
| % Growth | -217.6% | 173.1% | -40.9% | – |
| Operating Cash Flow | -$0 | $0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | $0 | -$0 | -$0 |